Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

In Vivo Evaluation of Preconditioned Adipose-Derived Stromal Cells Reveals Limited Impact on Vascular and ECM Remodeling in Polymer Scaffolds.

Pinheiro-Machado E., Kuiper T., Huurman RH., Petersen AH., Borghuis T., Smink AM.

Animal Study on Type 1 Diabetes, published in J Biomed Mater Res B Appl Biomater (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Biomed Mater Res B Appl Biomater (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
42084008
DOI
10.1002/jbm.b.70088

Abstract (original English)

Polymer scaffolds are a promising platform for the transplantation of insulin-producing cells in Type 1 Diabetes. While vascularization has been a primary focus due to its role in oxygen and nutrient delivery, the interplay between blood vessels and the extracellular matrix (ECM) is increasingly recognized as critical for establishing a stable and functional graft microenvironment. Adipose-derived stromal cells (ASC) have shown potential to support both vascular and ECM remodeling, and their therapeutic profile may be modulated through preconditioning. However, the in vivo effects of ASC preconditioning and their delivery remain poorly defined. This study aims to evaluate whether preconditioned ASC can enhance vascular and ECM outcomes in a polymer scaffold. To this end, rat ASC were preconditioned within porous polycaprolactone (PCL) scaffolds under normoxic, hypoxic, or hypoxic + high-glucose conditions. Subsequently, scaffolds were implanted subcutaneously in immunodeficient rats and explanted at 7, 14, 21, and 28 days for analysis of vascular and ECM markers. This study showed that the addition of ASC did not enhance vascularization or ECM remodeling within the scaffolds, regardless of whether the ASC were preconditioned. This indicates that previously reported in vitro benefits of ASC preconditioning do not necessarily translate in vivo. Moreover, the results highlight the

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsTissue ScaffoldsExtracellular MatrixAdipose TissueRatsPolyestersStromal CellsNeovascularization, PhysiologicMale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research